Patent · US Active

Antibodies against frizzled receptor

US10077304B2 · kind B2 · utility

0Cited by
51References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 14, 2014
Grant dateSep 18, 2018
Priority date—
Expiry dateAug 14, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides monoclonal antibodies that recognize one or more Frizzled receptors. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and prophylactic.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.